Stock Market Wire News Logo
Stock Market Wire News Logo
    • Login
    • Sign Up
Stock Information

Cannara Biotech Inc Company Name:

LOVFF Stock Symbol:

OTC Market:

MENU
LOVFF LOVFF Quote LOVFF Short LOVFF News LOVFF Articles LOVFF Message Board
Get LOVFF Alerts

News, Short Squeeze, Breakout and More Instantly...

RECENT LOVFF NEWS
  • LOVFF - Cannara Biotech Reports Q4 and Year-End 2019 Financial Results

    VANCOUVER , Nov. 26, 2019 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (CSE: LOVE) (FRA: 8CB) (OTCQB: LOVFF), an emerging vertically integrated cannabis company focused on indoor cultivation, processing and sale of premium cannabis and cannabis-infused produc...

  • LOVFF - Marijuana Stocks Targeting the Cannabis Beverages Market

    Send me an Investor Kit In December 2019, just over a year after the legalization of adult-use cannabis, Canada will undergo a second wave of cannabis legalization. While Canadians were initially denied the right to enjoy tasty cannabis treats, the national market will soon see a wave of...

  • LOVFF - Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce

    Cannara Biotech Secures $6 Million Mortgage Financing Facility with Canadian Imperial Bank of Commerce Canada NewsWire VANCOUVER, Oct. 10, 2019 VANCOUVER , Oct. 10, 2019 /CNW/ - Cannara Biotech Inc. ("Cannara Biotech" or the "Company") (CSE: LOVE) (OTCQB: LOVFF) (FRA: 8CB...

Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares


home / news releases / Cannara Biotech Announces Non-Brokered Private Placement of 12,000,000 Common Shares

  • July, 12 2019 07:30 AM
  • |
  • Canada Newswire
  • |
    • LOVFF
    • LOVFF Quote
    • LOVFF Short
    • LOVFF News
    • LOVFF Articles
    • LOVFF Message Board

Canada NewsWire

VANCOUVER, July 12, 2019

VANCOUVER, July 12, 2019 /CNW/ - Cannara Biotech Inc. (the "Corporation" or "Cannara") (CSE: LOVE) (FRA: 8CB) (OTCMKTS: LOVFF), an emerging vertically integrated Cannabis company focused on cultivation, and cannabis-infused products, is pleased to announce that it has raised $2,160,000 by way of non-brokered private placement of common shares of the Corporation (each a "Common Share" and collectively, the "Common Shares") at a price of $0.18 per Common Share (the "Offering"). The net proceeds from the Offering shall be used for general corporate purposes including the ongoing build-out at Cannara's facility and to provide additional working capital.

The Offering is expected to close on or about July 20, 2019 (the "Closing Date") and remains subject to approval of the Canadian Securities Exchange.

About Cannara Biotech
Cannara Biotech (CSE:LOVE) is building one of the largest indoor cannabis cultivation facilities (625,000 square feet) in Canada and the largest in Quebec. Leveraging Quebec's low electricity costs, Cannara Biotech's facility will produce premium-grade indoor cannabis and cannabis-infused products for the Canadian and international markets.

The CSE nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statement Regarding "Forward-Looking" Information

This information release contains certain forward-looking information. Such information involves known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by statements herein, and therefore these statements should not be read as guarantees of future performance or results. All forward-looking statements are based on the Company's current beliefs as well as assumptions made by and information currently available to it as well as other factors. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Due to risks and uncertainties, including the risks and uncertainties identified by the Company in its public securities filings, actual events may differ materially from current expectations. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

 

SOURCE Cannara Biotech Inc.

View original content: http://www.newswire.ca/en/releases/archive/July2019/12/c4572.html

Zohar Krivorot, President & CEO, zohar@cannara.ca; Lennie Ryer, CPA, CA, CFE, Chief Financial Officer, lennie@cannara.caCopyright CNW Group 2019

Tags
  • Biotechnology
  • IPO's
  • Medical Marijuana
Share This Post

Market Wire News is a media platform, the information on this page was provided by Canada Newswire via Quote Media. Read our full disclaimer.

Contact the Author

  • Research
  • Stock Search
  • News Releases
  • Articles
  • Message Boards
  • Trending Stocks
  • Short Information
  • Stock Wall
  • Member Benefits
  • Member Coins
  • Sign Up
  • Login
  • Contact

Sign up or login to continue

Sign up or login to continue.




Advertise

Brand your company, advertise your products or services with our ad programs.

Advertise

Research

Stock Search

News Releases

Articles

Message Boards

Trending Stocks

Short Information

Stock Wall

Members

Member Benefits

Member Coins


Log In

Sign Up

Stay Connected
Follow @marketWN

Contact

Privacy

Terms of Service

Disclaimer

© 2018 Market Wire News